CureDuchenne Cares Workshop: Sacramento, CA

  • Post author:
  • Post category:

CureDuchenne Cares Workshops: Hear The Latest From Experts April 4th, 2020, 8:00 am The Workshops program from CureDuchenne are day-long educational events that are oriented towards caregivers and Duchenne muscular…

Continue Reading CureDuchenne Cares Workshop: Sacramento, CA
New Equity Investment Aims to Develop New Duchenne Muscular Dystrophy Drug
source: pixabay.com

New Equity Investment Aims to Develop New Duchenne Muscular Dystrophy Drug

According to a story from CureDuchenne, the biotechnology company Dyne Therapeutics recently announced that CureDuchenne Ventures has made an equity investment that will support the development of all new precision…

Continue Reading New Equity Investment Aims to Develop New Duchenne Muscular Dystrophy Drug

CureDuchenne Cares Sessions: Boston, MA

  • Post author:
  • Post category:

CureDuchenne's Cares Sessions: Helping Connect and Inform Patient Families March 28th, 2020, 6:30 pm The Sessions program from CureDuchenne is geared specifically towards patients and their families as well as…

Continue Reading CureDuchenne Cares Sessions: Boston, MA

CureDuchenne Cares Session: Billings, MT

  • Post author:
  • Post category:

CureDuchenne's Cares Sessions: Helping Connect and Inform Patient Families March 21st, 2020, 6:30 pm The Sessions program from CureDuchenne is geared specifically towards patients and their families as well as…

Continue Reading CureDuchenne Cares Session: Billings, MT

CureDuchenne Cares Workshop: Phoenix, AZ

  • Post author:
  • Post category:

CureDuchenne Cares Workshops: Hear The Latest From Experts March 14th, 2020, 8:00 am The Workshops program from CureDuchenne are day-long educational events that are oriented towards caregivers and Duchenne muscular…

Continue Reading CureDuchenne Cares Workshop: Phoenix, AZ

CureDuchenne Cares Session: Knoxville, TN

  • Post author:
  • Post category:

CureDuchenne's Cares Sessions: Helping Connect and Inform Patient Families March 7th, 2020, 6:30 pm The Sessions program from CureDuchenne is geared specifically towards patients and their families as well as…

Continue Reading CureDuchenne Cares Session: Knoxville, TN
Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy
source: pixabay.com

Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy

  Advances in medicine have been responsible for longer overall survival in patients with neurodegenerative-neuromuscular diseases. According to a recent report in RTMagazine, an increase in the number of patients…

Continue Reading Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy

CureDuchenne Cares Session: Charleston, SC

  • Post author:
  • Post category:

CureDuchenne's Cares Sessions: Helping Connect and Inform Patient Families February 22nd, 2020, 6:30 pm The Sessions program from CureDuchenne is geared specifically towards patients and their families as well as…

Continue Reading CureDuchenne Cares Session: Charleston, SC
AskFirst: A New Collaborative Program to Support Rare Disease Patients in Gene Therapy Clinical Trials
source: pixabay.com

AskFirst: A New Collaborative Program to Support Rare Disease Patients in Gene Therapy Clinical Trials

AskBio Asklepios BioPharmaceuticals (AskBio) was first founded in 2001. It is based out of North Carolina.  This company is dedicated to the research of gene therapies as potential therapeutic options…

Continue Reading AskFirst: A New Collaborative Program to Support Rare Disease Patients in Gene Therapy Clinical Trials

CureDuchenne Professional Course: Houston, TX

  • Post author:
  • Post category:

A Professional Course for Healthcare Providers This course has been verified by the Texas PT for 6.5 CCUs. The professional course is a valuable opportunity for caregivers and healthcare providers…

Continue Reading CureDuchenne Professional Course: Houston, TX

CureDuchenne Cares Workshop: Houston, TX

  • Post author:
  • Post category:

CureDuchenne Cares Workshops: Hear The Latest From Experts February 8th, 2020, 8:00 am The Workshops program from CureDuchenne are day-long educational events that are oriented towards caregivers and Duchenne muscular…

Continue Reading CureDuchenne Cares Workshop: Houston, TX
Translarna Results in a Preserved Ability to Walk in Those with Duchenne Muscular Dystrophy
Fotorech / Pixabay

Translarna Results in a Preserved Ability to Walk in Those with Duchenne Muscular Dystrophy

PTC Therapeutics is a pharmaceutical company that has been working with Translarna, a medication intended for the treatment of Duchenne muscular dystrophy (DMD). They analyzed this treatment and presented the…

Continue Reading Translarna Results in a Preserved Ability to Walk in Those with Duchenne Muscular Dystrophy

CureDuchenne Cares Session: Salt Lake City, UT

  • Post author:
  • Post category:

CureDuchenne's Cares Sessions: Helping Connect and Inform Patient Families February 1st, 2020, 6:30 pm The Sessions program from CureDuchenne is geared specifically towards patients and their families as well as…

Continue Reading CureDuchenne Cares Session: Salt Lake City, UT

CureDuchenne Cares Session: Riverside, CA

  • Post author:
  • Post category:

CureDuchenne's Cares Sessions: Helping Connect and Inform Patient Families January 11th, 2020, 6:30 pm The Sessions program from CureDuchenne is geared specifically towards patients and their families as well as…

Continue Reading CureDuchenne Cares Session: Riverside, CA
Treatment for Duchenne Muscular Dystrophy with Rare Mutations Accepted Under Accelerated Approval
source: pixabay.com

Treatment for Duchenne Muscular Dystrophy with Rare Mutations Accepted Under Accelerated Approval

According to a story from BioSpace, the US Food and Drug Administration (FDA) has recently approved the drug golodirsen (marketed as Vyondys 53) as a treatment for Duchenne muscular dystrophy…

Continue Reading Treatment for Duchenne Muscular Dystrophy with Rare Mutations Accepted Under Accelerated Approval
A New Pediatric Precision Medicine Center is Opening in Utah
source: pixabay.com

A New Pediatric Precision Medicine Center is Opening in Utah

A new precision medicine center, specifically for pediatrics, has launched in Utah. This new center is the result of collaborative efforts from the Intermountain Primary Children's Hospital, Intermountain Precision Genomics,…

Continue Reading A New Pediatric Precision Medicine Center is Opening in Utah
Two Nonprofits Award $200,000 Grant for Development of Duchenne Muscular Dystrophy Patient Reported Outcomes
source: pixabay.com

Two Nonprofits Award $200,000 Grant for Development of Duchenne Muscular Dystrophy Patient Reported Outcomes

According to a story from PR Newswire, the nonprofit groups Duchenne UK and Parent Project Muscular Dystrophy (PPMD) have jointly awarded grant funding to the tune of $200,000 to Dr.…

Continue Reading Two Nonprofits Award $200,000 Grant for Development of Duchenne Muscular Dystrophy Patient Reported Outcomes
Study Analyzes New Outcome Measure for Duchenne Muscular Dystrophy
luvqs / Pixabay

Study Analyzes New Outcome Measure for Duchenne Muscular Dystrophy

According to a story from BioSpace, a global collaborative called the Trajectory Analysis Project recently released a study that utilized the North Star Ambulatory Assessment (NSAA), a recently developed measurement…

Continue Reading Study Analyzes New Outcome Measure for Duchenne Muscular Dystrophy

Steadman Philippon Research Institute Receives Award for Duchenne Muscular Dystrophy Research

According to a story from Financial Buzz, the Steadman Philippon Research Institute (SPRI) recently received an award in research from the National Institutes of Health (NIH). The award is in…

Continue Reading Steadman Philippon Research Institute Receives Award for Duchenne Muscular Dystrophy Research
Advocates for Duchenne Muscular Dystrophy Start Company Designed to Collect Data Directly From Patients
rawpixel / Pixabay

Advocates for Duchenne Muscular Dystrophy Start Company Designed to Collect Data Directly From Patients

According to a story from Xconomy, the US Food and Drug Administration (FDA) made a controversial decision three years ago when it approved the drug eteplirsen as a treatment for…

Continue Reading Advocates for Duchenne Muscular Dystrophy Start Company Designed to Collect Data Directly From Patients